Storage depends on the product
There is no storage rule shared by all peptides: some products need cold storage and others do not, as of September 17, 2026.
Use the product label and the pharmacy's directions to check the requirements for that medicine.
Ask what a delayed parcel means for this product and who can check a storage concern.
Open the source notes
Warm delivery needs a clear response
As of September 17, 2026, the Food and Drug Administration (FDA) reports complaints about weight-loss injections made to order arriving warm or with too little cooling.
GLP-1 medicines are a group used for blood-sugar control or weight loss, depending on the product. Semaglutide appears in Ozempic and Wegovy; tirzepatide appears in Mounjaro and Zepbound.
As of September 17, 2026, FDA advises leaving a GLP-1 injection unused if it arrives warm or lacks enough cooling.
Get the pharmacy's instructions for a delivery concern, and write down the response.
Open the source notes
Know the help route before you need it
Ask which symptoms need a prompt call, which need urgent care and who is available when the person treating you is away.
MedlinePlus treats severe allergic reactions as emergencies and calls for emergency help when symptoms are severe, as of September 17, 2026.
Its examples include breathing trouble and swelling of the face or tongue.
For those severe symptoms, its guidance includes going to the nearest emergency room. Get emergency help rather than waiting for a reply to a routine message.
Open the source notes
A medicine problem can also be reported
Patients and health professionals can report medicine problems through FDA's free MedWatch service, as of September 17, 2026.
Keep the product name, pharmacy name and any label or delivery records with your account of what happened. Ask the person treating you about your own care needs too.